A Family of Helminth Molecules that Modulate Innate Cell Responses via Molecular Mimicry of Host Antimicrobial Peptides

English version České info

Over the last decade a significant number of studies have highlighted the central role of host antimicrobial (or defence) peptides in modulating the response of innate immune cells to pathogen-associated ligands. In humans, the most widely studied antimicrobial peptide is LL-37, a 37-residue peptide containing an amphipathic helix that is released via proteolytic cleavage of the precursor protein CAP18. Owing to its ability to protect against lethal endotoxaemia and clinically-relevant bacterial infections, LL-37 and its derivatives are seen as attractive candidates for anti-sepsis therapies. We have identified a novel family of molecules secreted by parasitic helminths (helminth defence molecules; HDMs) that exhibit similar biochemical and functional characteristics to human defence peptides, particularly CAP18. The HDM secreted by Fasciola hepatica (FhHDM-1) adopts a predominantly α-helical structure in solution. Processing of FhHDM-1 by F. hepatica cathepsin L1 releases a 34-residue C-terminal fragment containing a conserved amphipathic helix. This is analogous to the proteolytic processing of CAP18 to release LL-37, which modulates innate cell activation by classical toll-like receptor (TLR) ligands such as lipopolysaccharide (LPS). We show that full-length recombinant FhHDM-1 and a peptide analogue of the amphipathic C-terminus bind directly to LPS in a concentration-dependent manner, reducing its interaction with both LPS-binding protein (LBP) and the surface of macrophages. Furthermore, FhHDM-1 and the amphipathic C-terminal peptide protect mice against LPS-induced inflammation by significantly reducing the release of inflammatory mediators from macrophages. We propose that HDMs, by mimicking the function of host defence peptides, represent a novel family of innate cell modulators with therapeutic potential in anti-sepsis treatments and prevention of inflammation.

Vyšlo v časopise: A Family of Helminth Molecules that Modulate Innate Cell Responses via Molecular Mimicry of Host Antimicrobial Peptides. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1002042
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002042

Souhrn

Zdroje

1. MedzhitovR 2007 Recognition of microorganisms and activation of the immune response. Nature 449 819 826

2. CastellheimABrekkeOLEspevikTHarboeMMollnesTE 2009 Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 69 479 491

3. GiulianiAPirriGRinaldiAC 2010 Antimicrobial peptides: the LPS connection. Methods Mol Biol 618 137 154

4. HirschTMetzigMNiederbichlerASteinauHUErikssonE 2008 Role of host defense peptides of the innate immune response in sepsis. Shock 30 117 126

5. DossMWhiteMRTecleTHartshornKL 2010 Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 87 79 92

6. TecleTTripathiSHartshornKL 2010 Review: Defensins and cathelicidins in lung immunity. Innate Immun 16 151 159

7. AuvynetCRosensteinY 2009 Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 276 6497 6508

8. MurakamiTObataTKuwahara-AraiKTamuraHHiramatsuK 2009 Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Int Immunol 21 905 912

9. TecleTWhiteMRGantzDCrouchECHartshornKL 2007 Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol 178 8046 8052

10. MilesKClarkeDJLuWSibinskaZBeaumontPE 2009 Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol 183 2122 2132

11. HerbertDRHölscherCMohrsMArendseBSchwegmannA 2004 Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20 623 635

12. LeetoMHerbertDRMarillierRSchwegmannAFickL 2006 TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis. Am J Pathol 169 1701 1712

13. McDermottJRBartramREKnightPAMillerHRGarrodDR 2003 Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 100 7761 7766

14. FaridASJimiFInagaki-OharaKHoriiY 2008 Increased intestinal endotoxin absorption during enteric nematode but not protozoal infections through a mast cell-mediated mechanism. Shock 29 709 716

15. FerrazAACamposJMJúniorJGDe AlbuquerqueACFerrazEM 2005 Gut bacterial translocation and postoperative infections: a prospective study in schistosomotic patients. Surg Infect 6 197 201

16. OgunrinadeAAdegokeGO 1982 Bovine fascioliasis in Nigeria--intercurrent parasitic and bacterial infections. Trop Anim Health Prod 14 121 125

17. ValeroMANavarroMGarcia-BodelonMAMarcillaAMoralesM 2006 High risk of bacterobilia in advanced experimental chronic fasciolosis. Acta Trop 100 17 23

18. DonnellySO'NeillSMSekiyaMMulcahyGDaltonJP 2005 Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. Infect Immun 73 166 173

19. DonnellySStackCMO'NeillSMSayedAAWilliamsDL 2008 Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. FASEB J 22 4022 4032

20. McGonigleSDaltonJP 1995 Isolation of Fasciola hepatica haemoglobin. Parasitology 111 209 215

21. BendtsenJDNielsenHvon HeijneGBrunakS 2004 Improved prediction of signal peptides: SignalP 30. J Mol Biol 340 783 795

22. ZdobnovEMApweilerR 2001 InterProScan - an integration platform for the signature-recognition methods in InterPro. Bioinformatics 17 847 848

23. AltschulSFGishWMillerWMyersEWLipmanDJ 1990 Basic local alignment search tool. J Mol Biol 215 403 410

24. ZhaoQPMoonSULeeHWNaBKChoSY 2004 Evaluation of Clonorchis sinensis recombinant 7-kilodalton antigen for serodiagnosis of clonorchiasis. Clin Diagn Lab Immunol 11 814 817

25. RamaswamyKSalafskyBPotluriSHeYXLiJW 1995 Secretion of an anti-inflammatory, immunomodulatory factor by Schistosomulae of Schistosoma mansoni. J Inflamm 46 13 22

26. JonesDT 1999 Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292 195 202

27. SreeramaNWoodyRW 2000 Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem 287 252 260

28. JohnsonWC 1999 Analyzing protein circular dichroism spectra for accurate secondary structures. Proteins 35 307 312

29. PeruginiMASchuckPHowlettGJ 2000 Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid. J Biol Chem 275 36758 36765

30. SchuckP 2000 Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J 78 1606 1619

31. SchuckPPeruginiMAGonzalesNRHowlettGJSchubertD 2002 Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J 82 1096 1111

32. HancockREWSahlH 2006 Antimicrobial and host-defense peptides as new anti-infective strategies. Nat Biotechnol 24 1551 1557

33. RobinsonMWDaltonJPDonnellyS 2008 Helminth pathogen cathepsin proteases: it's a family affair. Trends Biochem Sci 33 601 608

34. RobinsonMWTortJFWongEDonnellySMLowtherJ 2008 Proteomic and phylogenetic analysis of the cathepsin L protease family of the helminth pathogen, Fasciola hepatica: expansion of a repertoire of virulence-associated factors. Mol Cell Proteomics 7 1111 1123

35. StackCMCaffreyCRDonnellySMSeshaadriALowtherJ 2008 Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. J Biol Chem 283 9896 9908

36. NagaokaIHirotaSNiyonsabaFHirataMAdachiY 2001 Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-α by blocking the binding of LPS to CD14+ cells. J Immunol 167 3329 3338

37. ZughaierSMShaferWMStephensDS 2005 Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol 7 1251 1262

38. BowdishDMDavidsonDJScottMGHancockRE 2005 Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 49 1727 32

39. BomanHG 1995 Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13 61 92

40. MookherjeeNHancockRE 2007 Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 64 922 933

41. SchauberJGalloRL 2008 Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 122 261 266

42. GennaroRZanettiM 2000 Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55 31 49

43. RissoA 2000 Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J Leukoc Biol 68 785 792

44. HancockRE 1997 Peptide antibiotics. Lancet 349 418 422

45. MookherjeeNRehaumeLMHancockRE 2007 Cathelicidins and functional analogues as antisepsis molecules. Expert Opin Ther Targets 11 993 1004

46. HazlettLWuM 2010 Defensins in innate immunity. Cell Tissue Res 343 175 188

47. DurrUHSudheendraUSRamamoorthyA 2006 LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758 1408 1425

48. AgerberthBGunneHOdebergJKognerPBomanHG 1995 FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 92 195 199

49. GudmundssonGHAgerberthBOdebergJBergmanTOlssonB 1996 The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238 325 332

50. LowtherJRobinsonMWDonnellySMXuWStackCM 2009 The importance of pH in regulating the function of Fasciola hepatica cathepsin L1 cysteine protease. PLoS Negl Trop Dis 3 e369

51. PorcelliFVerardiRShiLHenzler-WildmanKARamamoorthyA 2008 NMR Structure of the Cathelicidin-Derived Human Antimicrobial Peptide LL-37 in Dodecylphosphocholine Micelles. Biochemistry 47 5565 5572

52. KirikaeTHirataMYamasuHKirikaeFTamuraH 1998 Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun 66 1861 1868

53. LarrickJWHirataMBalintRFLeeJZhongJ 1995 Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 63 1291 1297

54. HancockREWScottMG 2000 The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97 8856 8861

55. HoessAWatsonSSiberGRLiddingtonR 1993 Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5. A° resolution. EMBO J 12 3351 3356

56. PorroM 1994 Structural basis of endotoxin recognition by natural polypeptides. Trends Microbiol 2 65 67

57. NellMJTjabringaGSWafelmanARVerrijkRHiemstraPS 2006 Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27 649 660

58. MorrisonDCDannerRLDinarelloCAMunfordRSNatansonC 1994 Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J Endotoxin Res 1 71 83

59. LehmannVFreudenbergMAGalanosC 1987 Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 165 657 663

60. BeutlerBHoebeKDuXUlevitchRJ 2003 How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74 479 485

61. SchultzHHumeJZhang deSGioanniniTLWeissJP 2007 A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells. J Immunol 179 2477 2484

62. StammeCWrightJR 1999 Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages. Am J Physiol 276 L540 547

63. WeersinkAJVan KesselKPVan der TolMEVerhoefJ 1994 Modulation of lipopolysaccharide binding to human granulocytes. Immunology 83 617 623

64. OnguruDLiangYGriffithQNikolajczykBMwinzi P etal 2011 Human schistosomiasis is associated with endotoxemia and toll-like receptor 2- and 4-bearing B cells. Am J Trop Med Hyg 84 321 324

65. MelhemRFLoVerdePT 1984 Mechanism of interaction of Salmonella and Schistosoma species. Infect Immun 44 274 281

66. TaiTYHsuCYChangHCLiuYK 1958 Typhoid and paratyphoid fevers occurring in cases of schistosomiasis. Chin Med J 76 426 435

67. GendrelDRichard-LenobleDKombilaMEngohanENardouM 1984 Schistosoma intercalatum and relapses of Salmonella infection in children. Am J Trop Med Hyg 33 1166 1169

68. KreiderTAnthonyRMUrban JFJrGauseWC 2007 Alternatively activated macrophages in helminth infections. Curr Opin Immunol 19 448 453

69. GordonSTaylorPR 2005 Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 953 964

70. MylonasKJNairMGPrieto-LafuenteLPaapeDAllenJE 2009 Alternatively activated macrophages elicited by helminth infection can be reprogrammed to enable microbial killing. J Immunol 182 3084 3094

71. VarinAMukhopadhyaySHerbeinGGordonS 2010 Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115 353 362

72. BrännströmKSellinMEHolmfeldtPBrattsandMGullbergM 2009 The Schistosoma mansoni protein Sm16/SmSLP/SmSPO-1 assembles into a nine-subunit oligomer with potential to inhibit Toll-like receptor signaling. Infect Immun 77 1144 1154

73. HuSWuZYangLFungMC 2009 Molecular cloning and expression of a functional anti-inflammatory protein, Sj16, of Schistosoma japonicum. Int J Parasitol 39 191 200

74. HadleyEBHancockRE 2010 Strategies for the Discovery and Advancement of Novel Cationic Antimicrobial Peptides. Curr Top Med Chem 8 1872 1881

75. JenssenHHancockRE 2010 Therapeutic potential of HDPs as immunomodulatory agents. Methods Mol Biol 618 329 347

76. RobinsonMWMenonRDonnellySMDaltonJPRanganathanS 2009 An integrated transcriptomic and proteomic analysis of the secretome of the helminth pathogen, Fasciola hepatica: proteins associated with invasion and infection of the mammalian host. Mol Cell Proteomics 8 1891 1907

77. LaueTMShahBDRidgewayTMPelletierSL 1992 Computeraided interpretation of analytical sedimentation data for proteins. HardingSERoweAJHortonJ Analytical Ultracentrifugation in Biochemistry and Polymer Science Cambridge The Royal Society of Chemistry 90 125 In

78. ThompsonJDHigginsDGGibsonTJ 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22 4673 4680

79. KumarSTamuraKNeiM 1994 MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers. Comput Appl Biosci 10 189 191

80. NagaokaIHirotaSNiyonsabaFHirataMAdachiY 2000 Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 9 972 982

81. DonnellySO'NeillSMStackCMRobinsonMWTurnbullL 2010 Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem 285 3383 3392